Authors: Khan, Faizan, Tritschler, Tobias, Kimpton, Miriam, Wells, Philip S, Kearon, Clive, Weitz, Jeffrey I, Büller, Harry R, Raskob, Gary E, Ageno, Walter, Couturaud, Francis, Prandoni, Paolo, Palareti, Gualtiero, Legnani, Cristina, Kyrle, Paul A, Eichinger, Sabine, Eischer, Lisbeth, Becattini, Cecilia, Agnelli, Giancarlo, Vedovati, Maria Cristina, Geersing, Geert-Jan, Takada, Toshihiko, Cosmi, Benilde, Aujesky, Drahomir, Marconi, Letizia, Palla, Antonio, Siragusa, Sergio, Bradbury, Charlotte A, Parpia, Sameer, Mallick, Ranjeeta, Lensing, Anthonie W A, Gebel, Martin, Grosso, Michael A, Thavorn, Kednapa, Hutton, Brian, Le Gal, Gregoire, Fergusson, Dean A, Rodger, Marc A
Venue: Annals of Internal Medicine
Type: Publication
Abstract: BACKGROUND The long-term risk for major bleeding in patients receiving extended (beyond the initial 3 to 6 months) anticoagulant therapy for a first unprovoked venous thromboembolism (VTE) is uncertain. PURPOSE To determine the incidence of major bleeding during extended anticoagulation of up to 5 years among patients with a first unprovoked VTE, overall, and in clinically important subgroups. DATA SOURCES MEDLINE, Embase, and the Cochrane Central Register of Controlled Trials from inception to 23 July 2021. STUDY SELECTION Randomized controlle...
(read more)
Topics: 
Internal medicine
Pediatrics
Surgery
DOI:
10.7326/m21-1094
(Found 2 versions)
Loading (it may take a couple of seconds)...
Loading (it may take a couple of seconds)...